1 2 2 5 a r t I C l e S Short tandem nucleotide repeats and microsatellites are common features of mammalian genomes. Expansion of a hexanucleotide G4C2 repeat in the noncoding region of chromosome 9 open reading frame 72 (C9orf72) is the most common genetic cause for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. Growing evidence suggests that C9orf72 repeat expansions also contribute to a wide spectrum of neurodegenerative diseases such as Alzheimer's, Huntington's, multiple sclerosis, Parkinson's disease and cerebellar ataxias 1 . Approximately half of nonpathogenic C9orf72 alleles possess two G4C2 repeats, and the remaining half have two to 25 repeats 2 . The pathogenic expanded-repeat length, on the other hand, varies from tens to thousands 3 . C9orf72 expansions are bidirectionally transcribed, leading to the formation of intracellular sense and antisense RNA repeat-expansion foci (RRE). Moreover, the transcripts are prone to repeat-associated non-ATG translation, producing dipeptide repeat proteins (DPRs). Although a molecular understanding of C9orf72 pathological phenotypes is beginning to emerge, the mechanisms by which the G4C2 repeat expansions cause ALS and frontotemporal dementia are not clear.
1 2 2 6 VOLUME 20 | NUMBER 9 | SEPTEMBER 2017 nature neurOSCIenCe a r t I C l e S expression of 69 DPRs led to ~8 R-loop foci per cell, both of which were statistically higher than in control cells ( Fig. 1b ; P = 0.046 and P = 0.003, respectively) but were not statistically distinct from each other ( Fig. 1b ; P = 0.1). These observations suggest that C9orf72 RNA-repeat expansions and poly-GA DPRs cause an increase in Rloop formation. To test if this is also true in bona fide postmitotic neurons, we transduced rat cortical neurons with adeno-associated serotype 9 (AAV9) viral particles expressing 10 or 102 RREs (Fig. 1c ) or 34 or 69 DPRs (Fig. 1d) . Similarly to human cells, expressing 102 RREs led to increased R-loop foci compared to control cells and cells transduced with 10 RREs ( Fig. 1c ; P = 0.018). Likewise, expressing 34 or 69 DPRs increased the number of R-loop foci ( Fig. 1d ; P = 0.001 and P = 0.0002, respectively), though the difference between 34 and 69 was not statistically significant ( Fig. 1d ; P = 0.07). Together, these data show that G4C2 repeat expansions and poly-GA DPRs cause R-loop formation in mammalian cells.
Persistent accumulation of R-loops causes DNA double strand breaks (DSBs) and genome instability 8 . To test whether G4C2 repeat expansions cause DSBs, we co-transfected MRC5 cells with 10 or 102 RREs alongside GFP and examined DNA DSBs by immunostaining for γH2AX (Ser-139 phosphorylated histone H2AX), an established marker for DSBs. As anticipated, expression of 102 RREs led to a significant increase in the number of cells exhibiting more than 10 γH2AX foci, when compared to control cells and cells expressing 10 RREs ( Fig. 1e ; P = 0.005). Direct quantification of DSBs using the neutral comet assay revealed a similar increase in 102 RRE-transfected cells compared to controls ( Fig. 1f ; P = 0.006). Similarly, 34 or 69 DPR expression caused a significant increase in DSBs compared to controls, as measured by γH2AX immunostaining and the neutral comet assay (Fig. 1g,h ; P = 0.001 and P = 0.0003, respectively).
We next speculated that R-loops might drive the formation of DSBs in cells expressing C9orf72 repeat expansions. To directly test this hypothesis, we first assessed whether the elevated levels of R-loops observed in C9orf72 cells could be reduced by overexpressing the R-loop resolution helicase, senataxin (SETX) 9 . Whilst control adenovirus expression of RFP had no detectable impact on R-loops, expression of SETX from the same viral backbone led to a marked reduction of R-loop foci (Fig. 1i,j) . Overexpression of SETX, but not RFP, also reduced the number of γH2AX + cells ( Fig. 1i ; P = 0.01 and Fig. 1j ; P = 0.022), indicating that R-loops were a major source of C9orf72 expansion-driven DSBs. Furthermore, SETX expression reduced RREand DPR-driven cellular toxicity, as shown by a reduction in the percentage of cleaved-PARP1 + cells ( Fig. 1k,m ; P = 0.009 and P = 0.038, respectively) and by a similar reduction in the percentage of trypan blue-positive cells (Fig. 1l,n ; P = 0.037 and P = 0.025, respectively). The effect of SETX was specific to cells expressing 102 RREs or 69 DPRs, since it did not impact cell viability in control cells expressing 10-RRE or 0-DPR constructs ( Fig. 1k-n; all P > 0.05). Taken together, our data demonstrate that C9orf72 repeat expansions promote R-loopdriven DSB formation, which contributes to cellular toxicity.
The growing evidence that links C9orf72 repeat expansions to cerebellar ataxias 10, 11 prompted us to test whether the activation of the master DNA repair kinase, mutated in ataxia telangiectasia (ATM), is dysregulated in cells expressing C9orf72 expansions. Upon DNA breakage, ATM becomes activated in a process that involves its autophosphorylation at multiple sites, including serine 1981. This then sets in motion a cascade of downstream events resulting in 53BP1 recruitment and DNA repair [12] [13] [14] . While control cells displayed an average of two phosphorylated ATM (pATM) foci per nucleus, cells expressing DPRs ( Fig. 2a ; P = 0.002) or 102 RREs ( Fig. 2b ; P = 0.008) consistently displayed no, or in a few cases only one, focus.
The reduced number of pATM foci is unlikely to be due to reduced ATM expression, as shown by western blotting (Fig. 2c) . It was also not due to any artifact of expressing the V5 epitope tag or transfection associated toxicity, since transfection with a V5 empty or GFP plasmid did not result in defective ATM signaling (Supplementary Fig. 1 ). Since the accumulation of oxidative and protein-linked DNA breaks (PDBs) has been shown to cause neurodegeneration in man [15] [16] [17] , we next examined whether pATM foci would form normally following exposure to the topoisomerase I poison camptothecin (CPT) or tertbutyl hydroperoxide (TBH), inducers of PDBs and oxidative DNA breaks, respectively. Treatment with CPT or TBH led to prominent increase in pATM foci in control cells (Fig. 2d) . In marked contrast, cells expressing 34 or 69 DPRs (Fig. 2d) or 102 RREs ( Fig. 2e) were unable to respond to DNA damage to the same extent, consistently showing fewer pATM foci. We conclude from these experiments that the expression of C9orf72-related DPRs and RREs impaired ATM activation.
An important consequence of defective ATM signaling is the defective accumulation of nonhomologous end-joining repair factors, such as 53BP1, into nuclear foci 18 . As expected, expression of 34 or 69 DPRs led to a marked reduction in 53BP1 recruitment to nuclear foci when compared to control cells ( Fig. 3a ; P = 0.002). As was the case for pATM, this was not an artifact of expressing the V5 epitope tag used to visualize DPRs, nor was it due to transfection-related toxicity, as it was not observed in cells transfected with vectors encoding V5 or GFP (Supplementary Fig. 2a ). Consistent with defective ATM in DPR expressing cells, pretreatment with the ATM inhibitor Ku55933 significantly impaired 53BP1 foci formation in control cells but not in cells expressing 34 or 69 DPRs (Supplementary Fig. 2c,d) . As observed with DPRs, expression of 102 RREs also led to the suppression of 53BP1 foci formation, compared to mock-transfected cells and cells expressing 10 RREs ( Fig. 3b ; P = 0.035). Notably, whilst CPT induced a significant increase in 53BP1 foci in control cells ( Fig. 3c ; P = 0.009), expression of 34 or 69 DPRs prevented the CPT-induced increase in 53BP1 foci formation ( Fig. 3c ; P = 0.294). Similarly, expression of 102 RREs prevented the CPTinduced increase in 53BP1 foci formation ( Fig. 3d ; P = 0.496). To test whether this was also true in bona fide postmitotic neurons, we transduced rat cortical neurons with AAV9 viral particles expressing 34 or 69 DPRs or 10 or 102 RREs and examined 53BP1 foci formation following exposure to CPT (Fig. 3e,f) . Consistent with results using MRC5 cells, whilst control neurons exhibited about eight 53BP1 foci, those expressing 69 DPRs or 102 RREs showed three or one foci per cell, respectively ( Fig. 3e,f ; P < 0.01). Consistent with our transfection data, this was not an artifact of viral transduction, as cells transduced with AAV9 encoding V5 or GFP vectors possessed normal level of 53BP1 foci (Supplementary Fig. 2b) . Together, these data demonstrate that the expression of C9orf72-related RREs or DPRs suppresses 53BP1 recruitment to DSBs. To test whether the expression of C9orf72-related products results in defective phosphorylation of downstream ATM-effector proteins, we next examined the phosphorylation of P53, a known ATM target 19 . Whilst control cells displayed ~6-fold elevation of phosphorylated-P53 (p-P53) levels in response to CPT treatment ( Fig. 3g ; P = 0.037), cells expressing 34 or 69 DPRs showed no significant increase above baseline levels ( Fig. 3g ; P > 0.05). Consistent with the 53BP1 data, we also observed a defect in the recruitment of p-P53 to nuclear foci in DPR-expressing cells, which was mimicked in control cells by pretreatment with the ATM inhibitor ( Supplementary Fig. 2e) . Notably, ATM inhibition did not further attenuate p-P53 signaling in DPR + cells (P = 0.059 and P = 0.49 for 34 and 69 DPRs, respectively). Similarly, cells containing © 2017 Nature America, Inc., part of Springer Nature. All rights reserved. a r t I C l e S , presented and analyzed as in i and j. (l,n) HEK293T cells were mock-transduced or transduced with AAVs encoding SETX and transfected with (l) 10 or 102 RREs or (n) 0 or 69 DPRs. Left: cells were analyzed using trypan blue exclusion assays, and the percentage of trypan blue-permeable cells was quantified from 6 (l) and 4 (n) cell culture replicates (~200 cells each), and was presented and analyzed as in i and j. Right: whole-cell lysates from samples used in l and n were analyzed by western blotting, using anti-senataxin and anti-α-tubulin. *P < 0.05, **P < 0.01, ***P < 0.001; NS, nonsignificant.
a r t I C l e S 102 RREs failed to induce P53 phosphorylation following CPT exposure ( Fig. 3h ; P = 0.536), whilst mock-transfected cells and those expressing the 10 RREs did show increased p-P53 response to CPT treatment ( Fig. 3h ; P = 0.0143 and P = 0.01, respectively). Finally, to gain further evidence for defective ATM signaling, we next examined the accumulation of topoisomerase I (TOP1)-mediated PDBs, known as TOP1 cleavage complexes (TOP1cc). ATM deficiency in primary neural cultures and in rodent models has been shown to cause elevated levels of TOP1cc, interfering with transcription and contributing to neuronal cell death 20, 21 . Consistent with an ATM defect, cells expressing C9orf72-related DPRs or RREs exhibited ~4-fold increases in TOP1cc levels compared to controls ( Fig. 3i) . Taken together, these experiments reveal that C9orf72-related DPRs or RREs cause defective ATM signaling.
To further confirm ATM deficits in primary neural cultures we took advantage of observations that, in Atm knockout mice and ataxia telangiectasia patient tissue, histone deacetylase 4 (HDAC4) is abnormally localized to the nucleus of neurons 22 . To remain cytoplasmic, HDAC4 requires sustained phosphorylation, which is maintained by an intricate balance between phosphorylation and dephosphorylation. RREs. Cells were treated with 10 µM CPT for 40 min and subjected to CsCl step gradients, and fractions were slot-blotted with anti-TOP1. Bottom: the fold increase in TOP1cc, normalized to the mock-transfected baseline, was calculated and presented as the average from 2 cell culture replicates ± range. *P < 0.05, **P < 0.01, ***P < 0.001; NS, nonsignificant.
a r t I C l e S The latter is conducted by protein phosphatase 2A (PP2A), the activity of which is negatively regulated by ATM. Thus, ATM deficiency results in increased PP2A activity, leading to HDAC4 hypophosphorylation and, in turn, its relocalization to the nucleus. HDAC4 knockdown or inhibition and cytoplasmic HDAC4 conferred therapeutic benefit in vitro and in vivo models of ataxia telangiectasia 22 .
To test whether the ATM deficits triggered by C9orf72-related DPRs would also cause nuclear accumulation of HDAC4, we transduced rat cortical neurons with AAV9 viral particles expressing 69 DPRs and examined the cellular localization of HDAC4. Whilst HDAC4 appeared cytoplasmic in control neurons, it showed marked nuclear enrichment in neurons expressing 69 DPRs, with no detectable change in neuronal morphology (Supplementary Fig. 3a,c) . Subsequent quantification revealed ~3-fold increase in nuclear HDAC4 driven by 69 DPR expression ( Supplementary Fig. 3b ; P = 0.001). Nuclear accumulation of HDAC4 was not an artifact of viral transduction, as neurons transduced with AAV 9 encoding V5 empty or GFP displayed normal cytoplasmic HDAC4. Furthermore, pretreatment of primary neurons with an ATM inhibitor (Ku55933) similarly caused nuclear HDAC4 relocalization ( Supplementary Fig. 3d,e ), suggesting that the observed phenotype is due to ATM deficit. We next examined whether these observations were also true in vivo. To achieve this, AAV9 viral vectors encoding 10 or 102 RREs or 0 or 69 V5-tagged DPRs were delivered into the cerebrospinal fluid via cisterna magna of wild-type mice at postnatal day 1, which led to transgene expression in multiple areas of the CNS ( Supplementary  Fig. 4) . As was the case in vitro, expression of 102 RREs or 69 DPRs in mouse CNS tissue led to HDAC4 nuclear relocalization and accumulation of DSBs as measured by increased γH2AX foci ( Fig. 4a-d ; P < 0.05). We next tested whether the pronounced DNA repair defect observed in vivo would lead to neuronal cell death. Brain extracts from mice injected with 69 V5-tagged DPRs displayed ~2-fold increase in PARP1 cleavage compared to mice injected with 0 DPRs ( Fig. 4e ; P = 0.045). To further confirm the loss of neuronal cells in CNS tissue derived from DPR-injected mice, we used NeuN immunohistochemistry to quantify neurons from brainstem sections. Consistent with our western blotting data, we observed ~20% reduction in neurons from brainstem sections derived from mice injected with 69 DPRs when compared to mice injected with 0 DPRs ( Fig. 4f ; P = 0.048). Given the loss of neuronal cells, we anticipated that this would translate into a gross functional motor deficit at the whole organismal level. Indeed, at age 6 months, DPR-injected mice consistently displayed aberrant standing postures, swing speeds and stride lengths, when analyzed using a catwalk gait system ( Fig. 4g ; P < 0.01). At 12 months, we assessed the hindlimb splay of these mice using a manual scoring system. DPR-injected mice also displayed an increase in hindlimb splay ( Supplementary Fig. 5 ; P < 0.01). Taken together, these data demonstrate the expression of C9orf72-related RREs or DPRs cause ATM defects and DSBs in the murine nervous system and show that these observations are linked to a neurodegenerative phenotype in mammals, which is also consistent with the neurological deficits triggered by 50 poly-GA DPRs reported recently 23 .
After showing that poly-GA expression causes ATM dysfunction and neurodegeneration in mice, we next set out to get more insight into the molecular mechanism of the ATM defect. In response to DNA damage, ATM signaling is mediated by the Mre11-Rad50-Nbs1 (MRN) complex, which forms foci at sites of DSBs, facilitating interactions between ATM and Nbs1 24 and thereby enhancing ATM phosphorylation. Thus, we speculated that defective ATM signaling might be a consequence of upstream Nbs1 disruption. In contrast to 53BP1 and pATM, Nbs1 foci formed normally in DPR + cells ( Fig. 5a) .
Similarly to γH2AX, expression of 69 DPRs led to an increase in Nbs1 foci formation ( Fig. 5a ; P = 0.001). These data argue against the failure of Nbs1 recruitment as a cause for the C9orf72-related ATM defect.
Central to efficient ATM-mediated signaling is a cascade of posttranslational histone modifications required for efficient and sustained DSB repair. Part of this cascade is the ubiquitylation of histone H2A by the E3 ubiquitin ligase RNF168, which plays an important role in the recruitment of 53BP1 to DSBs [25] [26] [27] [28] [29] . Notably, RNF168-mediated H2A ubiquitylation and subsequent 53BP1 recruitment has also been shown to maintain efficient ATM signaling 30, 31 . We thus examined whether C9orf72 expansions would impact H2A ubiquitylation, which could explain the observed ATM signaling defect. Consistent with previous reports [27] [28] [29] , western blot analyses using H2A-specific antibodies revealed multiple ubiquitylated species (Fig. 5b) . The extent of H2A ubiquitylation, however, was attenuated in DPR + cells, which showed ~2-fold less H2A ubiquitylation in comparison to controls ( Fig. 5b ; P = 0.0042). Consistent with the western blotting data, immunostaining with specific ubiquitylated H2A (ub-H2A) antibodies also revealed reduced levels of ub-H2A foci in cells expressing 69 DPRs when compared to control cells ( Fig. 5c ; P = 0.013). Notably, although DPR + cells exhibited fewer ub-H2A foci, we noticed colocalization between DPRs and ub-H2A ( Fig. 5c ). Since RNF168 is the key ubiquitin ligase driving H2A ubiquitylation 32 , we wondered whether the defective ATM signaling was due to the decreased availability of RNF168. Consistent with this idea, increasing the pool of RNF168 by overexpression of GFP-RNF168 in DPR + cells restored 53BP1 ( Fig. 5d ; P = 0.0003) and increased pATM ( Fig. 5e ; P = 0.006) foci formation. Moreover, these experiments revealed that RNF168 was also sequestered into DPRs (Fig. 5d) , explaining the unexpected co-localization between DPRs and ub-H2A.
Inspired by a recent seminal report showing that an ALS-associated autophagy protein, P62 (also called SQSTM1), perturbs RNF168 function and impairs H2A ubiquitylation-mediated DNA repair 33 , we wondered whether the defective ATM signaling in C9orf72 models could result from a P62-mediated attenuation of H2A ubiquitylation. This hypothesis was particularly attractive since P62 accumulation is a hallmark pathology of C9orf72-related disease 34, 35 . If this is true, we predicted that depletion of P62 in DPR + cells would recapitulate the effect of RNF168 overexpression. Indeed, P62 depletion with siRNA ( Fig. 5f ) led to restoration of 53BP1 ( Fig. 5g ; P = 0.047) and pATM ( Fig. 5h ; P = 0.003) foci. These data are fully in line with reports that P62 accumulation impairs RNF168-mediated H2A ubiquitylation 33 and with studies that highlight the role of H2A ubiquitylation in ATM signaling 30, 31 . Furthermore, the restoration of ATM-mediated repair in DPR + cells by P62 depletion suppressed the number of DSBs ( Fig.  5i ; P = 0.029) and the aberrant accumulation of R-loops ( Fig. 5j ; P = 0.037). The latter is consistent with the recently reported reciprocal functional interaction between R-loops and ATM signaling 36, 37 .
The above data suggest that P62 accumulation and the consequential defect in ATM signaling act together with expansion-driven Rloops to trigger genome instability, though it is not clear whether they constitute distinct or epistatic pathways. To address this question, we examined whether SETX overexpression would further suppress the elevated level of DSBs in P62-depleted cells. Consistent with our previous data ( Figs. 1j and 5i) , overexpression of SETX or depletion of P62 was capable of reducing γH2AX foci in DPR + cells ( Fig. 5k ; P = 0.0013 and P = 0.0146, respectively). However, the concomitant overexpression of SETX and depletion of P62 further reduced DSB levels compared to levels observed by SETX overexpression or P62 depletion alone ( Fig. 5k ; P = 0.0433 and P = 0.0045, respectively) Together, these data identify two separate pathways that drive genome a r t I C l e S instability in DPR + cells. One is driven by P62 accumulation, defective H2A ubiquitylation and the subsequent ATM signaling defect; the other is driven by repeat-associated R-loop accumulation. Whilst the two pathways are distinct, crosstalk does exist, due to the reciprocal functional interaction between R-loops and ATM signaling 36, 37 .
In addition to DNA damage, ATM can also be activated in the absence of DNA damage by the drug chloroquine, a DNA intercalating agent 38 . Since the accumulation of P62 and inhibition of H2A ubiquitylation led to dysfunctional ATM signaling in C9orf72 cells, we reasoned that ATM activation by chloroquine, which is not linked to sensing DNA damage, would not be defective. Thus, we tested whether chloroquine-induced chromatin relaxation could restore ATM signaling in DPR + cells. As predicted, whilst DPR + cells did not display any ATM phosphorylation under normal conditions, chloroquine treatment led to pan-nuclear ATM phosphorylation ( Supplementary  Fig. 6a ; P = 0.004), indicating that DPR + cells were indeed responsive to chloroquine and, consequently, able to activate ATM. To test whether the ensuing ATM signaling was restored by chloroquine treatment in bona fide primary neuronal cells, we next examined the localization of HDAC4, which we demonstrated above is localized to the nucleus of neurons expressing DPRs. As predicted, whilst DPR + neurons displayed nuclear HDAC4, the addition of chloroquine a r t I C l e S led to HDAC4 being relocalized to the cytoplasm ( Supplementary  Fig. 6b ). Whilst only ~40% of DPR + neurons displayed cytoplasmic HDAC4 without chloroquine treatment, the number of neurons with cytoplasmic HDAC4 increased to almost 100% after cell treatment with chloroquine ( Supplementary Fig. 6b ; P = 0.014). These data demonstrate that ATM can be activated by inducing chromatin relaxation and are consistent with our previous data linking dysfunctional ATM signaling to a defect in histone ubiquitylation. Given that chromatin compaction has been reported in C9orf72 samples 39 , we speculated that an increase in heterochromatin formation might be a hallmark of C9orf72 DPR + cells. Using H3K9me3 as a marker for heterochromatin, we confirmed that DPR expression increases heterochromatin formation, as measured by ~50% increase in H3K9me3 signals identified by western blotting and immunocytochemistry, in comparison to empty vector control cells ( Supplementary Fig. 7a,b ; P = 0.002). Since ATM has been linked to the repair of heterochromatic DSBs 40 , we wondered whether promoting chromatin relaxation by Trichostatin A (TSA) 41, 42 would reduce DSBs levels in DPR + cells. Indeed, treatment of DPR + cells with TSA led to a reduction of H3K9me3 nuclear fluorescence ( Supplementary  Fig. 7c ; P = 0.002). Unlike chromatin relaxation by chloroquine, TSA treatment did appear to activate ATM signaling ( Supplementary  Fig. 7c ). TSA treatment did, however, lead to a reduction in γH2AX but not R-loop foci in DPR + cells ( Supplementary Fig. 7d,e ; P = 0.001), suggesting that chromatin relaxation reduces DSB levels by decreasing the requirement for ATM signaling, rather than activating ATM directly. This is in line with the reported role of ATM during the repair of heterochromatic DSBs, in which the DNA repair deficit caused by ATM inhibition is similarly overcome by chromatin relaxation 40 . Notably, TSA treatment increased DSB levels in control cells, suggesting that whilst TSA is beneficial in C9orf72 models in which the chromatin is compact, it may confer sensitivity to other types of DNA lesions in cells with nonpathological chromatin arrangements 41 . Finally, we wondered whether TSA treatment would also have beneficial effects on cell survival in C9orf72 models as a result of reduced DSBs. TSA treatment rescued the cell toxicity triggered by 69 DPR expression to a level similar to that observed in DMSO-treated control cells, as measured by both PARP1 cleavage ( Supplementary  Fig. 7f ; P = 0.0004) and trypan blue exclusion assays ( Supplementary  Fig. 7g ; P = 0.003). These data suggest that C9orf72-related DPRs drive the formation of heterochromatin, thereby exacerbating the ATM defect and ultimately leading to cell death.
Next, we set out to understand why C9orf72 cells display increased heterochromatin formation. Whilst R-loops are generally associated with euchromatin, their progressive accumulation may also drive heterochromatin formation 43, 44 . As such, we hypothesized that increased heterochromatin might be, at least in part, caused by the expansion-driven R-loops. SETX overexpression was able to reduce heterochromatin levels in DPR + cells (Supplementary Fig. 7h ; P = 0.031). Additionally, SETX overexpression did not further reduce DSBs in TSA-treated C9orf72 cells (Supplementary Fig. 7i ). Since ATM signaling is particularly important for the relaxation and subsequent repair of heterochromatic DNA 35 , we speculated that increased heterochromatin might also be a consequence of C9orf72-linked ATM dysfunction. We observed a reduction in H3K9me3 signal after restoring ATM signaling with P62 siRNA (Supplementary Fig. 7j ; P = 0.025). Similarly, the reduction of DSBs via P62 depletion appeared to be epistatic with TSA treatment (Supplementary Fig. 7k) . Taken together, these data demonstrate that chromatin relaxation via TSA attenuated heterochromatin levels, genomic instability and cellular toxicity in C9orf72 models. We propose a model in which C9orf72 repeat expansion drives the formation of heterochromatin, placing greater demand on ATM-mediated repair-a system that is already defective-and thereby creating a vicious cycle that leads to neuronal cell death. Although this is an attractive model for C9orf72 pathologies, we note that TSA can enhance DNA damage sensitivity in C9orf72-unrelated models 41, 45 , suggesting that the extent of heterochromatin and genome-wide distribution of breaks greatly influence the response of mammalian cells to TSA.
Finally, we examined whether R-loops, DNA breaks and defective ATM signaling observed in human cells, mouse neurons and mice were also present in C9orf72 ALS patient tissues. To test this, we subjected postmortem spinal cord sections from controls and C9orf72 ALS patients to R-loop, γH2AX and HDAC4 immunohistochemistry analyses. Consistent with our cellular data, we observed a significant increase in the number of R-loop ( Fig. 6a,b ; P = 0.0038) and γH2AX + motor neurons ( Fig. 6c,d Fig. 8 ). In addition, we observed an increase in the percentage of motor neurons with nuclear HDAC4 staining in C9orf72 ALS sections compared to controls ( Fig. 6e,f ; P = 0.0463), suggesting that ATM signaling was also dysregulated in C9orf72 ALS patient motor neurons. We note that nuclear accumulation of HDAC4 could also result from other factors, such as increased activity of the inhibitor of PP2A (I2PP2A), which has been observed in patients with sporadic ALS 46 . We also observed an increase in H3K9me3 nuclear fluorescence in C9orf72 ALS motor neurons ( Supplementary  Fig. 9 ; P = 0.022). Together, our findings are consistent with a model in which the expression of C9orf72-related products drive R-loop-mediated DNA breakage, which is further exacerbated by the suppression of ATM-mediated DSB repair, resulting in disruption of cotranscriptional processing and neurodegeneration (Supplementary Fig. 10) .
In summary, we identified an increase in R-loops and a defect in ATM signaling using four model systems: human cells, rodent neuronal cultures, RNA and dipeptide mouse models of C9orf72-related expansions, and postmortem ALS patient tissues. Consistent with an ATM defect, we found increased accumulation of TOP1-mediated PDBs, an established marker for neurodegeneration 20, 21, 47, 48 , in cells expressing C9orf72-related products. Furthermore, CNS tissues obtained from mice expressing C9orf72-related DPRs and from C9orf72 ALS patients exhibited nuclear HDAC4 retention, which is consistent with defective ATM signaling 22 . We further uncovered a link between pathological accumulations of P62-a hallmark of C9orf72 ALS-and defective H2A ubiquitylation, dysfunctional ATM-mediated DNA repair and increased genomic breaks. Our data reinforce the pathophysiological significance of the recently reported mechanism by which P62 impedes DNA damage repair 33 . A lengthdependent increase in R-loops was evident in cells expressing RREs, likely driven by G-rich RNA, which is prone to template strand invasion. Genome-wide analyses in yeast suggest that R-loops can regulate sense and antisense gene expression 49 , possibly explaining the aberrant expression of both transcript types in C9orf72 patient samples 50 . Notably, suppressing R-loop levels by SETX overexpression was able to reduce DSBs and cellular toxicity in both RRE and DPR models of C9orf72-related disease.
To conclude, we uncovered two distinct but partially overlapping pathways by which C9orf72 repeat expansions lead to genomic instability. One is driven by P62 accumulation, defective H2A ubiquitylation and defective ATM signaling, as measured by impaired 53BP1 foci formation and the phosphorylation of downstream target P53, the accumulation of TOP1 mediated PDBs and nuclear accumulation of HDAC4. The second is driven by the expansion-led increase in Rloop formation. Increased R-loops and defective ATM signaling can account for multiple yet unexplained phenotypes of C9orf72 repeat expansions: (i) increased heterochromatin, (ii) increased DSBs and (iii) the previously reported C9orf72-associated splicing defects 37 . Finally, this work suggests that targeted modulation of R-loop homeostasis by R-loop-specific helicases, or DSB repair kinetics by chromatin-modulating drugs, may offer new therapeutic opportunities for C9orf72-related neuropathologies.
MeTHoDS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. oNLINe MeTHoDS mammalian cell culture. MRC5 cells were grown in Minimum Essential Media (MEM; Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS; Sigma-Aldrich), 2 mM l-glutamine (Sigma-Aldrich) and 1% penicillin/streptomycin (Sigma-Aldrich). HEK293T cells were grown in Dulbecco's MEM (Sigma-Aldrich) supplemented with 10% FBS and 1% renicillin/streptomycin (Sigma-Aldrich). MRC5 cells were seeded on coverslips into the wells of a 24-well plate at a density of 3 × 10 5 cells/cm 2 . For other experiments, HEK293T cells were seeded into the wells of a 12-well plate at a density of 3 × 10 5 cells/cm 2 . The following day, cells were transfected with 250 ng of DNA/cm 2 of each DNA plasmid, using polyethylenimine at a molar concentration of 3:1 PEI:DNA. Six hours after transfection, the media was replaced and cells were incubated for a further 2 or 3 d, as indicated in the figure legends. For P62 knockdown experiments, MRC5 cells were co-transfected with cDNA plasmids using PEI (as described above) alongside control siRNA particles or P62-targeting particles (Santa Cruz, sc-29679) at a molarity of 25 nm. Dharmafect was used as the transfection reagent for all siRNA experiments at a ratio of 1:1 siRNA:Dharmafect. Recombinant adenovirus (adenovirus-type 5 dE1/E3) encoding for SETX or RFP were purchased from Vector Biolabs. Viral stocks (10 9 ) were diluted 1:5,000 for MRC5 and 1:20,000 for HEK293T cells, to give an approximate multiplicity of interest (MOI) of 10 and 2.5 for MRC5 and HEK293T cells, respectively. Virus-containing media was added for 2-3 h, before transfection, and replaced with fresh. For western blotting, cell death assays and comet assay experiments, MRC5 cells and HEK293T cells were grown for 72 h after transfection. For DNA repair immunocytochemistry assays, cells were grown for 48 h after transfection. generation of repeat expansion constructs. Synthesized TCGAC(G4C2) 10 sense and ACGT(G2C4) 10 antisense ssDNA oligonucleotides (Sigma-Aldrich) were designed with SalI/XhoI overhangs. The dsDNA oligos were generated by denaturing oligos at 99 °C for 30 min and then annealing by stepwise cooling at 0.5 °C/min. These (G4C2) 10 were ligated into SalI and XhoI digested pcDNA6.2-GW/EmGFP-miR (Invitrogen) to generate pcDNA6.2-GW/EmGFP-(G4C2) 10 . Further (G4C2) 102 repeats were subcloned using the 3′ XhoI site. pCMV-EmGFP-(G4C2)n vectors containing 10 and 102 repeats were generated via this method. EmGFP was subsequently excised using the flanking DraI restriction site. The (G4C2) 10 and (G4C2) 102 constructs were subcloned into pcDNA5/FRT/TO HIS (Addgene) using DraI and XhoI restriction sites. Transformations of plasmids containing the (G4C2)n repeat constructs were performed using recombination-deficient β-10 Escheria coli (NEB) to minimize (G4C2)n repeat shrinkage. To model gain-of-function via repeat-associated non-ATG (RAN) translation of C9orf72 repeat expansions, we produced two expression constructs coding for uninterrupted V5-tagged poly-GA DPRs, using an expandable cloning strategy with Age1 and Mre1 as compatible enzymes 51 . We first constructed a 'start acceptor' pCi-Neo vector (Promega) by cloning a V5-3xGA insert into the Xho1/Not1 sites (CTC GAG GCC ACC ATG GGC AAA CCG ATT CCG AAC CCG CTG CTG GGC CTG GAT AGC ACC GGT GCA GGT GCT GGC GCC GGC GGA TCC GAA TTC TAG CCG CGG CCG C) and a 'start donor' vector with a 14xGA insert (CTC GAG ACC GGT GCA GGT GCT GGA GCT GGT GCA GGT GCT GGA GCA GGT GCA GGT GCT GGA GCT GGT GCA GGT GCT GGA GCA GGT GCT GGC GCC GGC GGA TCC GAA TTC CCG CGG CCG C) in the Xho1/Not1 sites; we used these to propagate the GA repeats as shown below to construct 34 and 69 GA repeats. A V5 construct that lacked DPRs was created by AgeI and NGOMIV digestion, which excised the DPR coding region.
Primary cortical neuron cultures. The cortex from the brains of E17.5 rat pups were harvested and stored in Hank's Balanced Salt Solution (without calcium, without magnesium (HBSS−/−); Sigma-Aldrich). The tissue was washed with HBSS−/− and then incubated with 0.0035% trypsin (Sigma-Aldrich) for 15 min. DNAse (10 µg/mL; Sigma-Aldrich) was then added at a ratio of 1:1 (v/v), and the tissue was resuspended in 1 mL triturating solution (1% Albumax, 25 mg trypsin inhibitor, 10 µg/mL DNAse; Sigma-Aldrich). Neurobasal media (ThermoFisher), supplemented with 2 mM l-glutamine (Sigma-Aldrich), 1% penicillin/streptomycin (Sigma-Aldrich) and 1× B-27 (Sigma-Aldrich) was then added at a ratio of 1:5 (triturating solution:Neurobasal media). Cells were then plated onto poly-D-lysine coated coverslips in the wells of a 24 well-plate at a density of 9.365 × 10 4 cells/cm 2 . We added 1.5 × 10 5 viral genomes (vg) per cell of AAV9 to cultures after 5 d in vitro (DIV). Half of the culture media was replaced with fresh media every 3 d. Seven days after transduction (13 DIV), cells were treated with CPT (10 µM) where indicated and fixed using 4% paraformaldehyde or methanol:acetone (50:50).
Production of viral vectors. Sixty 15-cm plates containing HEK293T cells at a 80% confluence were transfected using polyethylenimine (MW ~25 K) with a mixture of three plasmids (at a molar ratio of 2:1:1 in order as listed) required to generate an infectious AAV9 viral particle: (i) a plasmid providing helper genes isolated from adenovirus, which enhance viral infectivity (pHelper); (ii) an ITRcontaining plasmid containing the 10 or 102 RRE or 34 or 69 DPR driven by the CMV promoter; and (iii) a plasmid that carries the AAV Rep-Cap proteins (pAAV2/9). A total of 52 µg of DNA was transfected per plate with pHelper:pAV2-CMV-GFP:pAAV2/9. For all experiments, we used the pAV2-CMV-GFP, consisting of two ITRs in a truncated genome that resulted in a self-complementary AAV9 (scAAV9). Four days after transfection, the AAV enriched media was collected, incubated at 37 °C for 2 h with 3,750 units of benzonase-nuclease (Sigma, USA), filtered through a 0.22-µm filter and concentrated to a volume of 1 mL using Amicon spin filter units (Millipore, USA). The virus was then washed with 50 mL of phosphate buffered saline (PBS, pH 7.3) in the same Amicon spin filter units and concentrated to a final volume of 0.5 mL. The viral sample volume was expanded to 14 mL with PBS and separated through a discontinuous iodixanol (D1556, Sigma, USA) gradient (4 mL of 54%, 9 mL of 40%, 9 mL of 25% and 5 mL of 15%) and centrifuged at 69,000 rpm for 1.5 h at 18 °C. The purified virus, which was found as a white layer between the 54% and 40% iodixanol gradient, was subsequently removed in 0.5-mL fractions using a syringe, and 10 µL of each fraction was mixed at an equal ratio with a 2× reducing sample of SDS-PAGE buffer, heated to 75 °C for 20 min, separated on a 4-20% precast TGX minigel (Bio-Rad, USA) and stained with Sypro-Ruby according to the manufacturer's protocol (Life Technologies, USA). Fractions that showed a pure virus composed solely of the VP1, VP2 and VP3 bands were combined and washed against five full volumes (15 mL each) of PBS with an Amicon spin filter, before being collected in a final volume of 300-500 µL. Concentrated viral stocks were stored at −80 °C until usage.
Viral titers were determined with the Quantifast SyBR Green PCR Kit (Qiagen, 204054) on a Bio-Rad CFX96 thermal cycler, following the manufacturer's instructions. The numbers of GFP copies in three dilutions of a purified AAV9 virus (100×, 1,000× and 10,000×) were compared to a standard curve generated by serial dilutions of a linearized pAV2-CMV-GFP vector. Primers used to quantify viral genomes were:
poly-A, forward: 5′-ATT TTA TGT TTC AGG TTC AGG GGG AGG TG-3′, reverse: 5′-GCG CAG AGA GGG AGT GGA CTA GT-3′; and GFP, forward: 5′-GAC GGC AAC ATC CTG GGG CAC AAG-3′, reverse: 5′-CGG CGG CGG TCA CGA ACT C-3′.
RnA fluorescent in situ hybridization (FISH). FISH was performed following a modification of the method described previously 52 . MRC5 cells or rat cortical neurons were fixed with 4% PFA for 10 min at room temperature. For S9.6 staining, however, fixation was performed using ice-cold methanol:acetone (50:50) for 10 min at −20 °C. Cells were then incubated with prehybridization buffer (50% formamide, 2× saline sodium citrate (SSC), 100 mg/mL dextran sulfate, 50 mM sodium phosphate; pH 7.0) for 1 h at 66 °C. Subsequently, cells were incubated with hybridization buffer containing a 5′ TYE-563-labeled locked nucleic acid (16-mer fluorescent)-incorporated DNA probe against the GGGGCC RNA hexanucleotide repeat (Exiqon, Inc., batch number 607323), at a concentration of 400 ng/mL for 1 h or overnight at 66 °C. A 1 h incubation period was preferred for pATM staining, due to the loss of antigen signal after overnight treatment in hybridization buffer. After hybridization, slides were washed once in 2× SSC with 0.1% Tween-20 at room temperature and three times in 0.1× SSC at 66 °C. All washes were performed for 10 min each. All solutions were made with DEPCtreated water. Following the completion of this FISH protocol, ICC was then performed as described below but using DEPC-treated PBS solutions.
Immunocytochemistry (Icc). MRC5 cells or rat cortical neurons were fixed with 4% PFA for 10 min at room temperature or with ice-cold methanol:acetone (50:50) for 10 min at −20 °C. Cells were then washed three times with PBS, incubated with 0.5% Triton-X 100 (in PBS) for 5 min and washed a further three times with PBS. In order to confirm the specificity of the anti-S9.6, MRC5 cells, fixed with methanol:acetone, were incubated with RNASE H enzyme (100 units/mL) in 3% BSA in PBS overnight at 4 °C before ICC or FISH-ICC. For ub-H2A staining, cells were incubated with PBS containing 0.5% Triton-X 100 for 2 min at room temperature (18-22 °C) before fixation with 4% PFA. Subsequently, cells were incubated with 3% BSA for 30 min, before being incubated with primary antibodies (in 3% BSA) for 1 h (with the exception of ub-H2A, which was incubated overnight at 4 °C). For DPR experiments, anti-V5 was always used to detect DPR + cells. Cells were washed 3× with PBS and incubated with fluorescent secondary antibodies (in 3% BSA) for 1 h, before being washed another 3× with PBS. Coverslips were mounted onto glass slides using Fluoromount aqueous mounting medium (Sigma-Aldrich).
Anti-V5 antibodies: mouse (Abcam, ab27671) and rabbit (Bethyl, A190-120A) were used at 1:1,000. A mouse anti-RNA:DNA hybrid anti-S9.6 (Kerafast, ENH001) and mouse anti-ub-H2a (Merck Millipore, E6C5) were used at concentrations of 1:500 each for immunocytochemistry and at 1:5,000 for FISH-ICC double staining. Mouse anti-γH2AX (Ser 139; Merck Millipore, JBW301), rabbit anti-53BP1 (Bethyl, A300-272A), rabbit anti-pATM (Abcam, EP1890Y), mouse anti-p-P53 (Cell Signaling, 9286s), mouse anti-cle-PARP (Cell Signaling, 9548) and rabbit anti-Nbs1 (Sigma, N3162) were all used at concentrations of 1:1,000. Rabbit anti-HDAC4 (Abcam, ab1437) was used at a concentration of 1:250. Rabbit anti-H3K9me3 (Abcam, ab8898) was used at a concentration of 1:2,000. Subsequently, cells were washed three times with PBS and incubated with the corresponding Alexa Fluor secondary antibodies (all purchased from Life Technologies and used at a concentration of 1:500) as well as DAPI for 1 h. For FISH-IF double staining, Alexa Fluor 488 was used in conjunction with the Cy3 fluorescent probe. Cells were washed a further three times with PBS and coverslips were mounted onto glass slides using Fluoromount Aqueous mounting medium (Sigma-Aldrich).
Immunohistochemistry. Mouse brain and spinal cord sections were incubated with 0.5% Triton-X 100 for 30 min, followed by incubation with 3% BSA (with 0.2% Triton-X 100) for 1 h. Subsequently, sections were incubated with primary antibodies (in 3% BSA with 0.2% Triton-X 100) overnight at 4 °C. The following day, sections were washed three times with PBS and incubated with fluorescent secondary antibodies alongside DAPI for 1 h at room temperature. For γH2AX and HDAC4 staining in DPR mice sections, a biotinylated secondary antibody was used in conjunction with tertiary anti-streptavidin Alexa Fluor 488 to enhance the signal. Sections were washed three more times, before mounting with Fluoromount Aqueous mounting medium (Sigma-Aldrich). For human spinal cord staining, 5 µm paraffin-embedded spinal cord sections from C9orf72 ALS and non-ALS controls (Supplementary table 1) were incubated with primary antibodies anti-HDAC4 (Abcam, ab1437), anti-γH2AX (R&D systems, AF2288), anti-S9.6 (Kerafast, ENH001) or anti-H3K9me3 (Abcam, ab8898) at concentrations of 1:250, 1:500, 1:1,000 and 1:1,000, respectively. Anti-NeuN D3S3I (Cell Signaling, cat. no. 12943) was used at a concentration of 1:500. Before primary antibody incubation, antigen retrieval was performed in 10 mM sodium citrate (pH 6) or 10 mM Tris Base for HDAC4, S9.6 and H3K9me3 or 1 mM EDTA (pH9) for γH2AX. Antigen retrieval was performed for 30 min in a pressure cooker. Immunohistochemistry was performed using the intelliPATH FLX Detection Kit, according to the manufacturer's protocol. Work on human tissue was reviewed by the Sheffield Brain Tissue Bank (SBTB) Management Board and approval to release tissue under REC 08/MRE00/103 was granted. All postmortem tissues stored at Sheffield Brain Tissue Bank were obtained with informed consent. cell lysis, SdS-PAge and western blotting. In order to collect whole-cell lysates, MRC5 cells, HEK 293T cells or mouse brainstem sections were lysed in RIPA buffer (150 mM NaCl, 0.5% sodium deoxycholate, 0.1% SDS and 50 mM Tris, pH 8.0, supplemented with protease inhibitor cocktail; Sigma-Aldrich) on ice for 30 min, before being sonicated in order to shear the DNA. To isolate chromatin fractions, the cytoplasmic and nuclear soluble proteins were first removed by hypotonic and hypertonic buffers. The remaining pellet was lysed with nuclear insoluble buffer (20 mM Tris, pH 8, 150 mM NaCl, 1% SDS and 1% NP-40) for 30 min on ice before being sonicated. The protein concentration of each whole-cell lysate was estimated using a BCA assay (Pierce), and equal quantities of protein were mixed with a 2× reducing sample SDS-PAGE buffer, heated to 95 °C for 5 min, separated on a 4-20% precast TGX minigel (Bio-Rad, USA) and transferred onto a PVDF membrane (Millipore, USA). Membranes were blocked with 3% BSA in TBS with 0.05% Tween (TBST) for 30 min, before incubating at either room temperature for 2 h or 4 °C overnight with agitation with primary antibody in 3% BSA in TBST. For western blotting, rabbit anti-ATM (Abcam, ab82512) was used at 1:2,000, rabbit anti-H3K9me3 (Abcam, ab8898) was used at 1:5,000, and mouse anti-α-tubulin (Abcam, T9026) and mouse anti-GAPDH (Calbiochem, CB1001) were used at 1:5,000. Anti-cle-PARP (Cell Signaling, 9548) was used at 1:1,000. Rabbit anti-H2A (Abcam, ab18255) was used at 1:1,000. Membranes were then washed three times for 5 min each with TBST and incubated with either an HRP-linked secondary anti-mouse antibody (Bio-Rad, 1721011) or an anti-rabbit antibody (Dako, D048701-2). Enhanced ChemiLuminescence (ECL) substrate was then added to the membrane to enable detection, and nonsaturated images were acquired using a G:BOX EF machine (Syngene) and Snapgene software (Syngene). Supplementary Figures 11-14 contain raw images of the western blots used in this study. trypan blue cell death assay. Three days after transfection, HEK293T cells were washed once with PBS and treated with trypsin until detached. Subsequently, 10% FBS-containing DMEM was added and cells were resuspended gently by pipetting up and down three times. Cell suspensions were then mixed with trypan blue (0.04%) at a ratio of 1:1. Immediately after, the percentage of cells that were permeable to trypan blue was calculated using a hemocytometer and a brightfield microscope. Scoring was performed under single-blinded conditions. measurement of topoisomerase I cleavage complexes (toP1cc). TOP1 protein-DNA complexes were purified using CsCl density gradients. Approximately 2 × 10 6 cells were lysed in 1% sarcosyl, 8 M guanidine HCl, 30 mM Tris, pH 7.5, and 10 mM EDTA. Cell lysates were then incubated at 70 °C for 15 min to remove all noncovalently bound proteins from DNA. Cell lysates were then loaded on a CsCl density step-gradient (5 mL total volume) and centrifuged at 75,600g at 25 °C for 24 h to separate free proteins from DNA. Ten consecutive 0.5-mL fractions were collected and slot blotted onto Hybond-C membrane (Amersham). To ensure equal DNA loading, the DNA concentration in each extract was determined fluorimetrically using PicoGreen (Molecular Probes/Invitrogen). Covalent TOP1-DNA complexes were then detected by immunoblotting with anti-TOP1 polyclonal antibodies (sc-32736, Santa Cruz.) and visualized by chemiluminescence.
neutral single-cell agarose gel electrophoresis (comet) assays. HEK293 cells were seeded at a density of 60,000 cells/24-well plates at 37 °C overnight. On the second day, cells were transfected using polyethyleneimine (PEI) 1 µg/µL transfection reagent with plasmid DNA 500 ng/well. Transfected cells were incubated at 37 °C for 24 h, and the complete media was then replaced with 1% FBS media and incubated for an additional 48 h. Transfection efficiency was assessed at ~75%. Cells were suspended in prechilled PBS and mixed with an equal volume of low-gelling-temperature agarose 1.3% (Sigma, Type VII) preserved at 42 °C. The cell mixture was immediately spread onto prechilled frosted glass slides (Fisher) precoated with 0.6% agarose. The slides were incubated at 4 °C in the dark until set and for all further steps. Slides were incubated in prechilled lysis buffer (2.5 M NaCl, 10 mM Tris-base, 100 mM EDTA (pH 8.0), 0.5% Triton-X 100, 1% Nlauroylsarcosine sodium salt and 3% DMSO; pH9.5) for 2 h. After incubation, the slides were washed with prechilled distilled water (2-10 min) and immersed for 1 h in prechilled electrophoresis buffer (300 mM sodium acetate, 100 mM Tris-HCl, 1% DMSO; pH8.3). Electrophoresis was conducted for 60 min at 1 V/cm, accompanied by washing three times with neutralization in 400 mM Tris-HCl (pH 7.5) for 15 min. Finally, slides were stained with DNA Sybr Green I nucleic (1:10,000, in PBS; Sigma) for 30 min. Tail-moment averages from 100 cells per sample were counted using Comet Assay IV software (Perceptive Instruments, UK). generation of AAV9-mediated mice. We injected 3 × 10 10 vg of purified scAAV into the cisterna magna of C57BL/6J postnatal day 1 (P1) wild-type mice under general anesthesia. P1 Pups were placed over a red light torch in prone position to enable visualization of the injection site. scAAV was loaded into a 5-µL syringe and the virus was injected at a flow rate of 1 µL/min. Animals were housed in groups of up to 5 per cage. Gender splits for each group were as followed: 0 DPRs, 6 M and 6 F; 69 DPRs, 7 M and 6 F; 10 RREs, 2 M and 1 F; and 102 RREs, 2 M and 1 F. Six or 12 months after injection, mice were killed for analysis by terminal anesthesia and transcardially perfused using a solution of PBS-heparin. Brain sections were then isolated and fixed using 4% PFA, overnight at 4 °C. After fixation, tissue was washed with PBS, cryoprotected in 30% sucrose at 4 °C and embedded in OCT (Cell Path). We sliced 20-or 40-µm brain coronal sections on a cryostat and then analyzed them using immunohistochemistry. Alternatively, brainstem portions were snap-frozen in liquid nitrogen and then lysed in RIPA buffer for western blotting analysis. All animal in vivo experiments were approved by the University of Sheffield Ethical Review Committee and performed according to the Animal (Scientific Procedures) Act 1986, under Project License 40/3739. Animals were administered AAV9 vectors at P1. To mitigate potential confounding of treatment with litter effects, a randomized block allocation design was used to ensure animals from a given litter were stratified across different treatment arms. Where there was only a single viable P1 pup in the litter, it was not allocated to treatment.
whole-animal neurological assays. All behavioral testing was performed at the same time of day (10:00-12:00 am). Gait and locomotion analysis at 6 months was performed by using the Catwalk system version 7.1. Briefly, 6-month-old mice (n = 12 and 13 for 0 DPRs and 69 DPRs, respectively) were placed on the Catwalk machine and crossed a glass plate in darkness whilst footprints were captured and recorded using Catwalk 7.1 software. Each animal performed the Catwalk assay up to six times and the best three runs were selected for analysis. Gait parameters (stand time, swing speed and stride length) were calculated for each limb using Catwalk 7.1. Power analysis using GPower version 3.0.3 was used to determine sample sizes. Based on α = 0.05 and a power of 80% (β = 0.8), a sample size of 12 was required to detect a 20% decrease in Catwalk performance at 6 months of age. Neuroscoring analysis was performed in mice aged 12 months (0 DPRs, n = 8; 69 DPRs, n = 9). Briefly, mice were suspended by the tail, and the splay defects were observed and scored individually for right and left hindlimbs, using a scale described previously: 0, normal splay; 1, mild defect; 2, moderate defect; 3, strong splay defect; 4, paralysed 53 . All behavioral tests were performed in blinded conditions, though neuroscoring splay analysis was performed under double-blinded conditions by a single observer.
Image acquisition and analysis. All representative images presented are z-stack projections acquired on a Leica SP5 confocal microscope, using the 63× 1.20 lens. For imaging cell monolayers, each stack was performed at 0.5-µm intervals, scanning the entire nucleus. In tissue sections, images were acquired using 1-µm z-stacks. Fluorescence intensity quantification was performed according to a method described previously 54 with some modifications. Using ImageJ, the corrected nuclear fluorescence value (CNF) of the relevant channel was calculated using the formula: CNF = integrated nuclear density -nuclear area × mean fluorescence of background. For in vitro foci counting, quantification was performed under the 100× lens of a Nikon Eclipse Ni microscope, with 20-100 cells/condition assessed (as indicated in the respective figure legends). For quantification of mouse brain sections, brainstem or cerebellar sections were imaged on a confocal microscope, as described above, and analyzed manually, with one exception: for γH2AX analysis in mice expressing 0 or 69 DPRs, foci quantification was automated using ImageJ. For human spinal cord sections, images were acquired using a Nikon Eclipse Ni microscope under the 100× and 20× objective lenses. Large motor neurons located in the ventral horn of spinal cord sections were considered for analysis; ~50 motor neurons (minimum 25) were analyzed from 6 C9orf72 ALS samples and 6 non-ALS samples. Motor neurons were considered R-loop + or γH2AX + when the whole nucleus was stained positive. We employed a double-blind randomization process in which experimental groups and the protein being analyzed were blinded for the person analyzing the data (for example, counting nuclear foci or taking micrographs). For H3K9me3 analysis, 4 controls and 4 C9orf72 ALS were imaged using a Leica LP5 confocal microscope and the mean fluorescence intensity (minus background signal) was calculated from 20 motor neurons per case. experimental repeats and statistical analysis. All data are presented as the means ± s.e.m. of three biological replicates, unless otherwise stated. Statistical differences were analyzed using Student's t tests for pairwise comparisons or one-way ANOVA (with Tukey's correction) for comparing groups of more than two but less than nine. P < 0.05 was considered statistically significant. Asterisks denote P < 0.05, double-asterisks denote P < 0.01 and triple asterisks denote P < 0.001; NS denotes P > 0.05. A Supplementary methods checklist is available.
data availability. The data that support the findings of this study are available from the corresponding authors upon reasonable request. Please note that in the event of publication, it is mandatory that authors include all relevant methodological and statistical information in the manuscript. For experiments reported in the text but not in the figures, please use the paragraph number instead of the figure number.
Statistics reporting, by figure
Note: Mean and standard deviation are not appropriate on small samples, and plotting independent data points is usually more informative. When technical replicates are reported, error and significance measures reflect the experimental variability and not the variability of the biological process; it is misleading not to state this clearly. Yes - Figures 1 -6 and Supplementary Figures 1 -9 2. For each representative image, is there a clear statement of how many times this experiment was successfully repeated and a discussion of any limitations in repeatability?
If so, where is this reported (section, paragraph #)?
Yes -This information is thoroughly explained in each figure legend, in-text where appropriate, and summarized in the methods section of the manuscript.
Statistics and general methods 1. Is there a justification of the sample size?
If so, how was it justified?
Where (section, paragraph #)?
Even if no sample size calculation was performed, authors should report why the sample size is adequate to measure their effect size.
Experiments involving measuring DNA damage and repair were conducted from al least 20 cells (neurons) or 50 cells (transformed cells) from three independant cell culture repeats. This sample size was adequate based on our and others previous studies in Nature and Nature Neuroscience, which ensures reproducibility of data. For animal work, power analysis using GPower version 3.0.3 was used to determine sample sizes. Based on α of 0.05 and a power of 80% (β=0.8) a sample size of 13 is required to detect a phenotype in Catwalk performance of 20% at 6 months of age.
2. Are statistical tests justified as appropriate for every figure?
Yes -statistical analyses are explained in each figure legend and justified in statistical section of methods.
a. If there is a section summarizing the statistical methods in the methods, is the statistical test for each experiment clearly defined?
Yes -statistical analyses are explained in each figure legend.
b. Do the data meet the assumptions of the specific statistical test you chose (e.g. normality for a parametric test)?
Where is this described (section, paragraph #)?
Yes -a section in methods describes the statistical tests used c. Is there any estimate of variance within each group of data?
Is the variance similar between groups that are being statistically compared?
Yes -our data display a continuous normal distribution in which we compare means from multiple biological replicates, thus we used parametric analyses. We used t-test for pair wise comparisons and ANOVA to compare groups more than two but less than 9. The choice of statistical method is described in a separate section in methods.
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February 2017 a. Is antibody catalog number given?
Where does this appear (section, paragraph #)?
Yes -It appears in all relevant sections of the methods such as Pages 19, 20, 21 and 22. b. Where were the validation data reported (citation, supplementary information, Antibodypedia)?
Validation data are included either in the main figures (e.g. Figure  1a where we show that RNase H treatment abolishes the S.96 signal) or in supplementary (e.g. Supplementary Figure 8 ). We have also cited papers that used our antibodies throughout the body of the manuscript. Where (section, paragraph #)?
Yes -Page 15, first paragraph.
All cell lines were routinely tested for Mycoplasma by both a DNA staining and imaging procedure, and by PCR.
